Does the cardioprotective effect of Empagliflozin involve inhibition of the sodium-proton exchanger?

Cardiovasc Res. 2021 Dec 17;117(14):2696-2698. doi: 10.1093/cvr/cvab137.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Benzhydryl Compounds / pharmacology
  • Glucosides / pharmacology
  • Protons*
  • Sodium*

Substances

  • Benzhydryl Compounds
  • Glucosides
  • Protons
  • Sodium
  • empagliflozin